Global and United States Patient Derived Xenograft/PDX Models Market Size, Status and Forecast 2020-2026

Global and United States Patient Derived Xenograft/PDX Models Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patient Derived Xenograft/PDX Models Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Gastrointestinal Tumor Models
1.2.3 Gynecological Tumor Models
1.2.4 Respiratory Tumor Models
1.2.5 Urological Tumor Models
1.2.6 Hematological Tumor Models
1.3 Market by Application
1.3.1 Global Patient Derived Xenograft/PDX Models Market Share by Application: 2020 VS 2026
1.3.2 Pre-clinical Drug Development and Basic Cancer Research
1.3.3 Biomarker Analysis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Patient Derived Xenograft/PDX Models Market Perspective (2015-2026)
2.2 Global Patient Derived Xenograft/PDX Models Growth Trends by Regions
2.2.1 Patient Derived Xenograft/PDX Models Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Patient Derived Xenograft/PDX Models Historic Market Share by Regions (2015-2020)
2.2.3 Patient Derived Xenograft/PDX Models Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patient Derived Xenograft/PDX Models Players by Market Size
3.1.1 Global Top Patient Derived Xenograft/PDX Models Players by Revenue (2015-2020)
3.1.2 Global Patient Derived Xenograft/PDX Models Revenue Market Share by Players (2015-2020)
3.2 Global Patient Derived Xenograft/PDX Models Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Patient Derived Xenograft/PDX Models Revenue
3.4 Global Patient Derived Xenograft/PDX Models Market Concentration Ratio
3.4.1 Global Patient Derived Xenograft/PDX Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patient Derived Xenograft/PDX Models Revenue in 2019
3.5 Key Players Patient Derived Xenograft/PDX Models Area Served
3.6 Key Players Patient Derived Xenograft/PDX Models Product Solution and Service
3.7 Date of Enter into Patient Derived Xenograft/PDX Models Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Patient Derived Xenograft/PDX Models Breakdown Data by Type (2015-2026)
4.1 Global Patient Derived Xenograft/PDX Models Historic Market Size by Type (2015-2020)
4.2 Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Type (2021-2026)
5 Patient Derived Xenograft/PDX Models Breakdown Data by Application (2015-2026)
5.1 Global Patient Derived Xenograft/PDX Models Historic Market Size by Application (2015-2020)
5.2 Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Patient Derived Xenograft/PDX Models Market Size (2015-2026)
6.2 North America Patient Derived Xenograft/PDX Models Market Size by Type (2015-2020)
6.3 North America Patient Derived Xenograft/PDX Models Market Size by Application (2015-2020)
6.4 North America Patient Derived Xenograft/PDX Models Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Patient Derived Xenograft/PDX Models Market Size (2015-2026)
7.2 Europe Patient Derived Xenograft/PDX Models Market Size by Type (2015-2020)
7.3 Europe Patient Derived Xenograft/PDX Models Market Size by Application (2015-2020)
7.4 Europe Patient Derived Xenograft/PDX Models Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Patient Derived Xenograft/PDX Models Market Size (2015-2026)
8.2 China Patient Derived Xenograft/PDX Models Market Size by Type (2015-2020)
8.3 China Patient Derived Xenograft/PDX Models Market Size by Application (2015-2020)
8.4 China Patient Derived Xenograft/PDX Models Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Patient Derived Xenograft/PDX Models Market Size (2015-2026)
9.2 Japan Patient Derived Xenograft/PDX Models Market Size by Type (2015-2020)
9.3 Japan Patient Derived Xenograft/PDX Models Market Size by Application (2015-2020)
9.4 Japan Patient Derived Xenograft/PDX Models Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Patient Derived Xenograft/PDX Models Market Size (2015-2026)
10.2 Southeast Asia Patient Derived Xenograft/PDX Models Market Size by Type (2015-2020)
10.3 Southeast Asia Patient Derived Xenograft/PDX Models Market Size by Application (2015-2020)
10.4 Southeast Asia Patient Derived Xenograft/PDX Models Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Details
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Patient Derived Xenograft/PDX Models Introduction
11.1.4 Crown Bioscience Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020))
11.1.5 Crown Bioscience Recent Development
11.2 The Jackson Laboratory
11.2.1 The Jackson Laboratory Company Details
11.2.2 The Jackson Laboratory Business Overview
11.2.3 The Jackson Laboratory Patient Derived Xenograft/PDX Models Introduction
11.2.4 The Jackson Laboratory Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020)
11.2.5 The Jackson Laboratory Recent Development
11.3 Champions Oncology
11.3.1 Champions Oncology Company Details
11.3.2 Champions Oncology Business Overview
11.3.3 Champions Oncology Patient Derived Xenograft/PDX Models Introduction
11.3.4 Champions Oncology Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020)
11.3.5 Champions Oncology Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Patient Derived Xenograft/PDX Models Introduction
11.4.4 Charles River Laboratories Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020)
11.4.5 Charles River Laboratories Recent Development
11.5 WuXi Apptec
11.5.1 WuXi Apptec Company Details
11.5.2 WuXi Apptec Business Overview
11.5.3 WuXi Apptec Patient Derived Xenograft/PDX Models Introduction
11.5.4 WuXi Apptec Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020)
11.5.5 WuXi Apptec Recent Development
11.6 Oncodesign
11.6.1 Oncodesign Company Details
11.6.2 Oncodesign Business Overview
11.6.3 Oncodesign Patient Derived Xenograft/PDX Models Introduction
11.6.4 Oncodesign Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020)
11.6.5 Oncodesign Recent Development
11.7 Horizon Discovery
11.7.1 Horizon Discovery Company Details
11.7.2 Horizon Discovery Business Overview
11.7.3 Horizon Discovery Patient Derived Xenograft/PDX Models Introduction
11.7.4 Horizon Discovery Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020)
11.7.5 Horizon Discovery Recent Development
11.8 Pharmatest Services
11.8.1 Pharmatest Services Company Details
11.8.2 Pharmatest Services Business Overview
11.8.3 Pharmatest Services Patient Derived Xenograft/PDX Models Introduction
11.8.4 Pharmatest Services Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020)
11.8.5 Pharmatest Services Recent Development
11.9 Hera Biolabs
11.9.1 Hera Biolabs Company Details
11.9.2 Hera Biolabs Business Overview
11.9.3 Hera Biolabs Patient Derived Xenograft/PDX Models Introduction
11.9.4 Hera Biolabs Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020)
11.9.5 Hera Biolabs Recent Development
11.10 EPO Berlin-Buch
11.10.1 EPO Berlin-Buch Company Details
11.10.2 EPO Berlin-Buch Business Overview
11.10.3 EPO Berlin-Buch Patient Derived Xenograft/PDX Models Introduction
11.10.4 EPO Berlin-Buch Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020)
11.10.5 EPO Berlin-Buch Recent Development
11.11 Xentech
10.11.1 Xentech Company Details
10.11.2 Xentech Business Overview
10.11.3 Xentech Patient Derived Xenograft/PDX Models Introduction
10.11.4 Xentech Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020)
10.11.5 Xentech Recent Development
11.12 Urolead
10.12.1 Urolead Company Details
10.12.2 Urolead Business Overview
10.12.3 Urolead Patient Derived Xenograft/PDX Models Introduction
10.12.4 Urolead Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020)
10.12.5 Urolead Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Patient Derived Xenograft/PDX Models Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Gastrointestinal Tumor Models
Table 4. Key Players of Gynecological Tumor Models
Table 5. Key Players of Respiratory Tumor Models
Table 6. Key Players of Urological Tumor Models
Table 7. Key Players of Hematological Tumor Models
Table 8. Global Patient Derived Xenograft/PDX Models Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Patient Derived Xenograft/PDX Models Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Patient Derived Xenograft/PDX Models Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Patient Derived Xenograft/PDX Models Market Share by Regions (2015-2020)
Table 12. Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Patient Derived Xenograft/PDX Models Market Share by Regions (2021-2026)
Table 14. Patient Derived Xenograft/PDX Models Market Market Trends
Table 15. Patient Derived Xenograft/PDX Models Market Drivers
Table 16. Patient Derived Xenograft/PDX Models Market Challenges
Table 17. Patient Derived Xenograft/PDX Models Market Restraints
Table 18. Global Patient Derived Xenograft/PDX Models Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Patient Derived Xenograft/PDX Models Market Share by Players (2015-2020)
Table 20. Global Top Patient Derived Xenograft/PDX Models Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Patient Derived Xenograft/PDX Models as of 2019)
Table 21. Global Patient Derived Xenograft/PDX Models by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Patient Derived Xenograft/PDX Models Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Patient Derived Xenograft/PDX Models Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Patient Derived Xenograft/PDX Models Market Size Share by Type (2015-2020)
Table 27. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Type (2021-2026)
Table 28. Global Patient Derived Xenograft/PDX Models Market Size Share by Application (2015-2020)
Table 29. Global Patient Derived Xenograft/PDX Models Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Patient Derived Xenograft/PDX Models Market Size Share by Application (2021-2026)
Table 31. North America Patient Derived Xenograft/PDX Models Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Patient Derived Xenograft/PDX Models Market Share by Type (2015-2020)
Table 33. North America Patient Derived Xenograft/PDX Models Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Patient Derived Xenograft/PDX Models Market Share by Application (2015-2020)
Table 35. North America Patient Derived Xenograft/PDX Models Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Patient Derived Xenograft/PDX Models Market Share by Country (2015-2020)
Table 37. Europe Patient Derived Xenograft/PDX Models Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Patient Derived Xenograft/PDX Models Market Share by Type (2015-2020)
Table 39. Europe Patient Derived Xenograft/PDX Models Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Patient Derived Xenograft/PDX Models Market Share by Application (2015-2020)
Table 41. Europe Patient Derived Xenograft/PDX Models Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Patient Derived Xenograft/PDX Models Market Share by Country (2015-2020)
Table 43. China Patient Derived Xenograft/PDX Models Market Size by Type (2015-2020) (US$ Million)
Table 44. China Patient Derived Xenograft/PDX Models Market Share by Type (2015-2020)
Table 45. China Patient Derived Xenograft/PDX Models Market Size by Application (2015-2020) (US$ Million)
Table 46. China Patient Derived Xenograft/PDX Models Market Share by Application (2015-2020)
Table 47. China Patient Derived Xenograft/PDX Models Market Size by Region (US$ Million) (2015-2020)
Table 48. China Patient Derived Xenograft/PDX Models Market Share by Region (2015-2020)
Table 49. Japan Patient Derived Xenograft/PDX Models Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Patient Derived Xenograft/PDX Models Market Share by Type (2015-2020)
Table 51. Japan Patient Derived Xenograft/PDX Models Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Patient Derived Xenograft/PDX Models Market Share by Application (2015-2020)
Table 53. Japan Patient Derived Xenograft/PDX Models Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Patient Derived Xenograft/PDX Models Market Share by Country (2015-2020)
Table 55. Southeast Asia Patient Derived Xenograft/PDX Models Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Patient Derived Xenograft/PDX Models Market Share by Type (2015-2020)
Table 57. Southeast Asia Patient Derived Xenograft/PDX Models Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Patient Derived Xenograft/PDX Models Market Share by Application (2015-2020)
Table 59. Southeast Asia Patient Derived Xenograft/PDX Models Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Patient Derived Xenograft/PDX Models Market Share by Country (2015-2020)
Table 61. Crown Bioscience Company Details
Table 62. Crown Bioscience Business Overview
Table 63. Crown Bioscience Product
Table 64. Crown Bioscience Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020) (US$ Million)
Table 65. Crown Bioscience Recent Development
Table 66. The Jackson Laboratory Company Details
Table 67. The Jackson Laboratory Business Overview
Table 68. The Jackson Laboratory Product
Table 69. The Jackson Laboratory Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020) (US$ Million)
Table 70. The Jackson Laboratory Recent Development
Table 71. Champions Oncology Company Details
Table 72. Champions Oncology Business Overview
Table 73. Champions Oncology Product
Table 74. Champions Oncology Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020) (US$ Million)
Table 75. Champions Oncology Recent Development
Table 76. Charles River Laboratories Company Details
Table 77. Charles River Laboratories Business Overview
Table 78. Charles River Laboratories Product
Table 79. Charles River Laboratories Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020) (US$ Million)
Table 80. Charles River Laboratories Recent Development
Table 81. WuXi Apptec Company Details
Table 82. WuXi Apptec Business Overview
Table 83. WuXi Apptec Product
Table 84. WuXi Apptec Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020) (US$ Million)
Table 85. WuXi Apptec Recent Development
Table 86. Oncodesign Company Details
Table 87. Oncodesign Business Overview
Table 88. Oncodesign Product
Table 89. Oncodesign Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020) (US$ Million)
Table 90. Oncodesign Recent Development
Table 91. Horizon Discovery Company Details
Table 92. Horizon Discovery Business Overview
Table 93. Horizon Discovery Product
Table 94. Horizon Discovery Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020) (US$ Million)
Table 95. Horizon Discovery Recent Development
Table 96. Pharmatest Services Business Overview
Table 97. Pharmatest Services Product
Table 98. Pharmatest Services Company Details
Table 99. Pharmatest Services Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020) (US$ Million)
Table 100. Pharmatest Services Recent Development
Table 101. Hera Biolabs Company Details
Table 102. Hera Biolabs Business Overview
Table 103. Hera Biolabs Product
Table 104. Hera Biolabs Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020) (US$ Million)
Table 105. Hera Biolabs Recent Development
Table 106. EPO Berlin-Buch Company Details
Table 107. EPO Berlin-Buch Business Overview
Table 108. EPO Berlin-Buch Product
Table 109. EPO Berlin-Buch Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020) (US$ Million)
Table 110. EPO Berlin-Buch Recent Development
Table 111. Xentech Company Details
Table 112. Xentech Business Overview
Table 113. Xentech Product
Table 114. Xentech Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020) (US$ Million)
Table 115. Xentech Recent Development
Table 116. Urolead Company Details
Table 117. Urolead Business Overview
Table 118. Urolead Product
Table 119. Urolead Revenue in Patient Derived Xenograft/PDX Models Business (2015-2020) (US$ Million)
Table 120. Urolead Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Patient Derived Xenograft/PDX Models Market Share by Type: 2020 VS 2026
Figure 2. Gastrointestinal Tumor Models Features
Figure 3. Gynecological Tumor Models Features
Figure 4. Respiratory Tumor Models Features
Figure 5. Urological Tumor Models Features
Figure 6. Hematological Tumor Models Features
Figure 7. Global Patient Derived Xenograft/PDX Models Market Share by Application: 2020 VS 2026
Figure 8. Pre-clinical Drug Development and Basic Cancer Research Case Studies
Figure 9. Biomarker Analysis Case Studies
Figure 10. Patient Derived Xenograft/PDX Models Report Years Considered
Figure 11. Global Patient Derived Xenograft/PDX Models Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Patient Derived Xenograft/PDX Models Market Share by Regions: 2020 VS 2026
Figure 13. Global Patient Derived Xenograft/PDX Models Market Share by Regions (2021-2026)
Figure 14. Global Patient Derived Xenograft/PDX Models Market Share by Players in 2019
Figure 15. Global Top Patient Derived Xenograft/PDX Models Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Patient Derived Xenograft/PDX Models as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Patient Derived Xenograft/PDX Models Revenue in 2019
Figure 17. North America Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Patient Derived Xenograft/PDX Models Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Crown Bioscience Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2015-2020)
Figure 45. The Jackson Laboratory Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2015-2020)
Figure 46. Champions Oncology Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2015-2020)
Figure 47. Charles River Laboratories Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2015-2020)
Figure 48. WuXi Apptec Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2015-2020)
Figure 49. Oncodesign Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2015-2020)
Figure 50. Horizon Discovery Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2015-2020)
Figure 51. Pharmatest Services Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2015-2020)
Figure 52. Hera Biolabs Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2015-2020)
Figure 53. EPO Berlin-Buch Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2015-2020)
Figure 54. Xentech Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2015-2020)
Figure 55. Urolead Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs